nVerses Capital LLC Purchases New Position in Xylem Inc. (NYSE:XYL)

nVerses Capital LLC purchased a new stake in shares of Xylem Inc. (NYSE:XYLFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 2,600 shares of the industrial products company’s stock, valued at approximately $353,000.

Several other hedge funds and other institutional investors also recently modified their holdings of XYL. EverSource Wealth Advisors LLC increased its stake in shares of Xylem by 68.8% during the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after purchasing an additional 77 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Xylem by 3.5% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 2,317 shares of the industrial products company’s stock valued at $299,000 after purchasing an additional 79 shares in the last quarter. Waycross Investment Management Co increased its stake in shares of Xylem by 1.8% during the second quarter. Waycross Investment Management Co now owns 4,895 shares of the industrial products company’s stock valued at $664,000 after purchasing an additional 87 shares in the last quarter. Bleakley Financial Group LLC increased its stake in shares of Xylem by 2.3% during the first quarter. Bleakley Financial Group LLC now owns 4,042 shares of the industrial products company’s stock valued at $522,000 after purchasing an additional 90 shares in the last quarter. Finally, Brown Advisory Inc. increased its stake in shares of Xylem by 1.1% during the fourth quarter. Brown Advisory Inc. now owns 8,203 shares of the industrial products company’s stock valued at $938,000 after purchasing an additional 92 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on XYL shares. Stifel Nicolaus raised their target price on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Oppenheimer raised their price target on shares of Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Royal Bank of Canada raised their price target on shares of Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. Robert W. Baird raised their price target on shares of Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. Finally, UBS Group assumed coverage on shares of Xylem in a research report on Tuesday, August 13th. They set a “buy” rating and a $165.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $147.54.

View Our Latest Report on Xylem

Xylem Stock Performance

XYL stock traded up $1.76 on Friday, hitting $137.53. The company had a trading volume of 1,263,088 shares, compared to its average volume of 1,117,877. Xylem Inc. has a 12-month low of $87.59 and a 12-month high of $146.08. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The stock’s 50-day simple moving average is $134.76 and its 200 day simple moving average is $133.54. The stock has a market cap of $33.40 billion, a price-to-earnings ratio of 48.94, a P/E/G ratio of 2.42 and a beta of 1.04.

Xylem (NYSE:XYLGet Free Report) last issued its earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company had revenue of $2.17 billion for the quarter, compared to analysts’ expectations of $2.14 billion. During the same quarter last year, the company posted $0.98 earnings per share. The firm’s quarterly revenue was up 26.0% on a year-over-year basis. As a group, equities research analysts expect that Xylem Inc. will post 4.25 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date is Thursday, August 29th. Xylem’s payout ratio is 51.25%.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the sale, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, SVP Rodney Aulick sold 21,800 shares of the company’s stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the transaction, the senior vice president now owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the transaction, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.